ArticleWorld journal of urology2026
Anatomical, functional, and patient-reported outcomes following anterior urethroplasty. Can we predict when and why are patients with anatomical recurrences requiring reinterventions?
Article in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeDespite modern advances in urethroplasty, little consensus exists on defining treatment success. The absence of reintervention was the main benchmark. However, recent efforts incorporate anatomical, functional and patient-reported criteria. Our aim is to evaluate urethroplasty outcomes using these four criteria, and to assess the progression of asymptomatic anatomical recurrences to predict the need for future treatments.
methodsAn ambispective study was conducted on patients > 18 years undergoing anterior urethroplasty between 2020 and 2023. Minimum follow-up of 2 years. Techniques included anastomotic and augmentation urethroplasties. Follow-up performing urine culture, uroflowmetry, self-administered questionnaires, and endoscopic/radiological imaging. Success was defined as: anatomical (passage of a 17Ch cystoscope or normal urethrogram), functional (Qmax > 10 mL/s), asymptomatic (no urinary symptoms or infections), no need for further treatments, and overall success.
results138 patients were followed for a mean of 35 months (IQR = 24.4–63.8). Success rates were: anatomical 68.8%, functional 71.7%, asymptomatic and retreatment-free 79%, and overall success 63.8%. USS-PROM and quality of life scores improved significantly with high satisfaction levels and maintained IIEF-5 scores. Among the 43 patients with anatomical recurrences, 22 were asymptomatic (51.2%) when re-stricture was identified. After 35 months, 16 out of 22 (72.7%) remained symptom-free. All symptomatic progressions, leading to further interventions, developed during the first 18 months.
conclusionsAnatomical and functional criteria result in lower success rates than symptoms-based or retreatment definitions. Most patients with asymptomatic anatomical strictures who do not develop symptoms in the first 18 months remain stable and do not require secondary treatments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.